Literature DB >> 35332460

Anhedonia in Anxiety Disorders.

Charles T Taylor1,2, Samantha N Hoffman3, Amanda J Khan4.   

Abstract

Humans, like other animals, are fundamentally motivated to pursue rewarding outcomes and avoid aversive ones. Anxiety disorders are conceptualized, defined, and treated based on heightened sensitivity to perceived aversive outcomes, including imminent threats as well as those that are uncertain yet could occur in the future. Avoidance is the central strategy used to mitigate anticipated aversive outcomes - often at the cost of sacrificing potential rewards and hindering people from obtaining desired outcomes. It is for these reasons that people are often motivated to seek treatment. In this chapter, we consider whether and how anhedonia - the loss of interest in pursuing and/or reduced responsiveness to rewarding outcomes - may serve as a barrier to recovering from clinically impairing anxiety. Increasingly recognized as a prominent symptom in many individuals with elevated anxiety, anhedonia is not explicitly considered within prevailing theoretical models or treatment approaches of anxiety. Our goal, therefore, is to review what is known about anhedonia within the anxiety disorders and then integrate this knowledge into a functional perspective to consider how anhedonia could maintain anxiety and limit treatment response. Our overarching thesis is that anhedonia disrupts the key processes that are central to supporting anxiety recovery. We end this chapter by considering how explicitly targeting anhedonia in treatment can optimize outcomes for anxiety disorders.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Anhedonia; Anxiety; Positive affect; Reward; Threat; Treatment

Mesh:

Year:  2022        PMID: 35332460     DOI: 10.1007/7854_2022_319

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  69 in total

1.  Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal.

Authors:  T A Brown; B F Chorpita; D H Barlow
Journal:  J Abnorm Psychol       Date:  1998-05

2.  In search of durable positive psychology interventions: Predictors and consequences of long-term positive behavior change.

Authors:  Michael A Cohn; Barbara L Fredrickson
Journal:  J Posit Psychol       Date:  2010-09-01

3.  Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.

Authors:  Roee Admon; Roselinde H Kaiser; Daniel G Dillon; Miranda Beltzer; Franziska Goer; David P Olson; Gordana Vitaliano; Diego A Pizzagalli
Journal:  Am J Psychiatry       Date:  2016-10-24       Impact factor: 18.112

4.  Reduced optimism and a heightened neural response to everyday worries are specific to generalized anxiety disorder, and not seen in social anxiety.

Authors:  K S Blair; M Otero; C Teng; M Geraci; M Ernst; R J R Blair; D S Pine; C Grillon
Journal:  Psychol Med       Date:  2017-03-14       Impact factor: 7.723

5.  Predictors of Generalized Anxiety Disorder stigma.

Authors:  Philip J Batterham; Kathleen M Griffiths; Lisa J Barney; Alison Parsons
Journal:  Psychiatry Res       Date:  2012-12-04       Impact factor: 3.222

Review 6.  Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications.

Authors:  L A Clark; D Watson
Journal:  J Abnorm Psychol       Date:  1991-08

7.  NEURAL REACTIVITY TO REWARD AS A PREDICTOR OF COGNITIVE BEHAVIORAL THERAPY RESPONSE IN ANXIETY AND DEPRESSION.

Authors:  Katie L Burkhouse; Autumn Kujawa; Amy E Kennedy; Stewart A Shankman; Scott A Langenecker; K Luan Phan; Heide Klumpp
Journal:  Depress Anxiety       Date:  2016-04       Impact factor: 6.505

8.  Social anxiety and the interpretation of positive social events.

Authors:  Lynn E Alden; Charles T Taylor; Tanna M J B Mellings; Judith M Laposa
Journal:  J Anxiety Disord       Date:  2007-05-24

9.  Neural Responsiveness to Reward as an Index of Depressive Symptom Change Following Cognitive-Behavioral Therapy and SSRI Treatment.

Authors:  Katie L Burkhouse; Stephanie M Gorka; Heide Klumpp; Amy E Kennedy; Shannon Karich; Jennifer Francis; Olusola Ajilore; Michelle G Craske; Scott A Langenecker; Stewart A Shankman; Greg Hajcak; K Luan Phan
Journal:  J Clin Psychiatry       Date:  2018-06-12       Impact factor: 4.384

10.  Neuroticism and reward-related ventral striatum activity: Probing vulnerability to stress-related depression.

Authors:  Erin Bondy; David A A Baranger; Jared Balbona; Kendall Sputo; Sarah E Paul; Thomas F Oltmanns; Ryan Bogdan
Journal:  J Abnorm Psychol       Date:  2021-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.